openPR Logo

Press Releases from Exactitude Consultancy (21426 total)

Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile …

Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion

Partial Epilepsy Market to Reach USD 9.36 Billion by 2034

Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion

Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …

Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is

Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di …

Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by

Pouchitis Market to Reach USD 1.12 Billion by 2034

Pune, India - December 2025 - The global Pouchitis Market, valued at USD 612.4 million in 2024, is projected to reach USD 1.12 billion by

Pituitary Stalk Interruption Syndrome (PSIS) Market to Reach USD 52.8 Million by …

Pune, India - December 2025 - The global Pituitary Stalk Interruption Syndrome (PSIS) Market, valued at USD 27.6 million in 2024, is projected to reach

Metachromatic Leukodystrophy Market to Reach USD 182.6 Million by 2034

Pune, India - December 2025 - The global Metachromatic Leukodystrophy (MLD) Market, valued at USD 62.4 million in 2024, is projected to reach USD 182.6

Lymphedema Market to Reach USD 2.58 Billion by 2034 Driven by Rising Cancer Surg …

Pune, India - December 2025 - The global Lymphedema Market, valued at USD 1.48 billion in 2024, is projected to reach USD 2.58 billion by

Isovaleric Acidemia Market to Reach USD 38.6 Million by 2034

Pune, India - December 2025 - The global Isovaleric Acidemia Market, valued at USD 19.4 million in 2024, is projected to reach USD 38.6 million

Diabetic Foot Ulcers Market to Reach USD 9.84 Billion by 2034 Driven

Pune, India - December 2025 - The global Diabetic Foot Ulcers Market, valued at USD 5.26 billion in 2024, is projected to reach USD 9.84

Turner Syndrome Market to Reach USD 2.14 Billion by 2034 Driven by Advances in H …

Pune, India - December 2025 - The global Turner Syndrome Market, valued at USD 1.28 billion in 2024, is expected to reach USD 2.14 billion

Severe Hypoglycemia Market to Reach USD 6.42 Billion by 2034

Pune, India - December 2025 - The global Severe Hypoglycemia Market, valued at USD 3.42 billion in 2024, is projected to reach USD 6.42 billion

Sandhoff Disease Market to Reach USD 72.4 Million by 2034 Driven

Pune, India - December 2025 - The global Sandhoff Disease Market, valued at USD 29.6 million in 2024, is expected to reach USD 72.4 million

Virtual Biopsy Market to Reach USD 4.12 Billion by 2034 Driven by AI Imaging

Pune, India - December 2025 - The global Virtual Biopsy Market, valued at USD 1.12 billion in 2024, is projected to reach USD 4.12 billion

Cosmetic Surgery Market to Reach USD 97.24 Billion by 2034

Pune, India - December 2025 - The global Cosmetic Surgery Market, valued at USD 49.88 billion in 2024, is projected to reach USD 97.24 billion

Urinary Catheters Market to Reach USD 3.84 Billion by 2034

Pune, India - December 2025 - The global Urinary Catheters Market, valued at USD 2.18 billion in 2024, is projected to reach USD 3.84 billion

Breath Analyzers Market to Reach USD 3.42 Billion by 2034

Pune, India - December 2025 - The global Breath Analyzers Market, valued at USD 1.82 billion in 2024, is projected to reach USD 3.42 billion

Software as a Medical Device (SaMD) Market to Reach USD 17.54 Billion by 2034 Fu …

Pune, India - December 2025 - The global Software as a Medical Device (SaMD) Market, valued at USD 5.98 billion in 2024, is projected to

DNA Test Kits Market to Reach USD 4.86 Billion by 2034 Driven by Rise in Ancestr …

Pune, India - December 2025 - The global DNA Test Kits Market, valued at USD 1.98 billion in 2024, is projected to reach USD 4.86

Spinal Cord Injury (SCI) - Epidemiology Forecast & Market Outlook to 2034

Disease Background & Classification Spinal Cord Injury (SCI) is a neurological condition caused by traumatic or non-traumatic damage to the spinal cord, resulting in varying degrees

Global Vagus Nerve Stimulator (VNS) Market Accelerates as Neuromodulation Expand …

Market Definition The Vagus Nerve Stimulator (VNS) Market includes implantable and non-invasive devices that deliver electrical impulses to the vagus nerve to modulate neurological, psychiatric, and

Sleep Apnea Implants Market Expands as Hypoglossal Nerve Stimulation Becomes a P …

Market Definition The Sleep Apnea Implants Market includes implantable medical devices used to treat moderate to severe obstructive sleep apnea in patients who cannot tolerate or

Pediatric Neurology Devices Market Grows as Childhood Neuro Disorders, EEG Adopt …

Market Definition The Pediatric Neurology Devices Market includes technologies used to diagnose, monitor, and support treatment of neurological conditions in infants, children, and adolescents. Key device

Intracranial Stents Market Accelerates as Stroke and Aneurysm Treatment Shifts T …

Market Definition The Intracranial Stents Market includes stents specifically designed for cerebral arteries to treat: • Wide-necked intracranial aneurysms (as scaffolding for coil placement) • Intracranial atherosclerotic disease (ICAD) causing

Intracranial Aneurysms Market Strengthens as Endovascular Therapies Become Globa …

Market Definition The intracranial aneurysms market includes all devices and technologies used for diagnosing and treating aneurysmal dilatations in the cerebral arteries. This primarily covers: • Endovascular devices o Detachable

Interventional Neuroradiology Market Expands as Stroke, Aneurysm, and Complex Ne …

Market Definition Interventional Neuroradiology (INR)-also known as Endovascular Neurosurgery or Neurointerventional Surgery-is a subspecialty focused on minimally invasive, image-guided treatment of vascular and structural diseases of

Circadian Rhythm Sleep Disorders (CRSD) Market Expands as Light-Therapy Devices, …

Keyword Definition Circadian Rhythm Sleep Disorders (CRSDs) are conditions caused by a misalignment between an individual's internal biological clock and the external environment. Major CRSD types

Carotid Stenotic Scan Devices Market Grows with Rising Stroke Prevention Program …

Carotid Stenotic Scan Devices Market Grows with Rising Stroke Prevention Programs and Wider Use of Duplex Ultrasound, CTA, and MRA Carotid stenotic scan devices comprise the

Adult Intraventricular Haemorrhage (IVH) Market Strengthens with Advanced Neuroc …

The Adult Intraventricular Haemorrhage (IVH) market is evolving from basic ventricular drainage and supportive care into a more technology-driven neurocritical care segment. As stroke centres

Parkinson's Disease - Patient Pool Analysis & Market Outlook

What is Parkinson's disease? Parkinson's disease (PD) is a chronic, progressive neurodegenerative disorder caused by loss of dopaminergic neurons in the substantia nigra. Core clinical features

Developmental and Epileptic Encephalopathies (DEE) - Patient Pool Analysis & Mar …

What are DEEs? Developmental and epileptic encephalopathies (DEEs) are a group of rare, severe, early-onset epilepsies in which epileptic activity itself contributes to progressive cognitive, motor

Cell and Gene Therapy in Parkinson's Disease Market Accelerates as Regenerative …

The Cell and Gene Therapy in Parkinson's Disease (PD) market is moving from concept to commercial reality. With pluripotent stem cell-derived dopaminergic neuron grafts now

Treatment-Resistant Depression (TRD) Market Expands as Rapid-Acting Therapies, N …

The Treatment-Resistant Depression (TRD) market is undergoing one of the fastest transformations in psychiatry. Traditional SSRIs and SNRIs fail to deliver sustained remission for a

Primary Ciliary Dyskinesia (PCD) Market Expands as Genetic Testing, Early Diagno …

The Primary Ciliary Dyskinesia (PCD) market is transitioning from a historically underdiagnosed condition to an increasingly recognized rare respiratory disease. Advances in molecular diagnostics, increased

Major Depressive Disorder (MDD) Market Grows as New Mechanisms, Digital Therapie …

The Major Depressive Disorder (MDD) market is moving beyond traditional monoamine antidepressants into a more diversified, innovation-driven space. While SSRIs and SNRIs remain the workhorses

Lambert-Eaton Myasthenic Syndrome (LEMS) Market Grows as Amifampridine, Immunoth …

The Lambert-Eaton Myasthenic Syndrome (LEMS) market is evolving from a tiny, under-recognized niche to a structured rare-disease segment anchored by amifampridine, immunomodulatory therapies, and oncology

Complex Regional Pain Syndrome (CRPS) Market Expands as Neuromodulation, Non-Opi …

The Complex Regional Pain Syndrome (CRPS) market is shifting from fragmented, trial-and-error pharmacotherapy to structured, multidisciplinary, and technology-enabled care. As clinicians move away from chronic

Traumatic Brain Injury (TBI) Market Accelerates as Advanced Monitoring, Neurocri …

The Traumatic Brain Injury (TBI) Market is transitioning from basic acute stabilization to a full continuum-of-care model that spans pre-hospital triage, neurocritical care, advanced monitoring,

Complex Regional Pain Syndrome (CRPS) Market Expands as Neuropathic Pain Therapi …

The Complex Regional Pain Syndrome (CRPS) Market is rapidly evolving as healthcare systems recognize the importance of early intervention in this debilitating neuropathic pain condition.

West Syndrome Market Rises as Early Diagnosis, Hormonal Therapy, and Novel AEDs …

The West Syndrome Market is moving from under-recognized niche to a focused rare-epilepsy segment with meaningful commercial potential. As clinicians and parents become more aware

Treatment-Resistant Depression (TRD) Market Expands as Novel Mechanisms, Rapid-A …

The Treatment-Resistant Depression (TRD) Market is entering one of the most dynamic phases in the history of psychiatry. Traditional monoaminergic antidepressants leave a large share

Transient Ischemic Attack (TIA) Market Grows as Early Diagnosis, AI-Enabled Stro …

The Transient Ischemic Attack (TIA) Market is transforming as healthcare systems shift focus from delayed stroke management to rapid TIA triage and prevention. With TIAs

Subarachnoid Hemorrhage (SAH) Market Expands as Minimally Invasive Neurosurgery, …

The Subarachnoid Hemorrhage (SAH) Market is undergoing significant modernization. Once dominated by high mortality and limited interventions, the field now benefits from advanced neuroimaging, early

Spasticity Market Strengthens as Oral Agents, Botulinum Toxins, and Intrathecal …

The global Spasticity Market is shifting from basic symptomatic relief toward structured, multi-modal management. Neurologists, rehabilitation physicians, and surgeons are increasingly combining oral antispastic agents,

Secondary Progressive Multiple Sclerosis (SPMS) Drug Market Grows as Oral S1P Mo …

The Secondary Progressive Multiple Sclerosis (SPMS) drug market is entering a more innovation-rich phase. As better diagnostics and longer survival increase the number of patients

Primary Progressive Aphasia (PPA) Market Accelerates as Speech Therapies, Digita …

The Primary Progressive Aphasia (PPA) market, once an overlooked niche within dementia care, is becoming a focused, innovation-driven segment. As diagnosis improves and frontotemporal dementia

Partial Paralysis Market Set to Reach USD 15 Billion as Neurorehabilitation and …

The Partial Paralysis Market is transitioning from conventional physiotherapy-led care to a technology-enabled, highly specialized treatment ecosystem. With growing investments in neurorehabilitation devices, robotics, electrical

Opioid Overdose Treatment Market Expands as Naloxone Access, Harm Reduction, and …

The Opioid Overdose Treatment Market is in a critical growth phase as governments, NGOs, and healthcare systems respond to tens of thousands of opioid deaths

Schizophrenia Market Evolves as Novel Mechanisms, Long-Acting Injectables, and D …

The Schizophrenia Market is entering a new innovation cycle. While antipsychotics remain the backbone of care, unmet needs around negative symptoms, cognition, metabolic side effects,

Precocious Puberty Market Grows as Rising Diagnosis Rates and Long-Acting Hormon …

The Precocious Puberty Market is entering a solid growth phase as more children are diagnosed and treated earlier for hormonally driven early sexual maturation. With

Go To Page:   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20